<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="8" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font1" size="8" family="AkzidenzGroteskBE-Md,Bold" color="#000000"/>
	<fontspec id="font2" size="8" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font3" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font4" size="10" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font5" size="10" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font6" size="9" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font7" size="7" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font8" size="8" family="AkzidenzGroteskBE" color="#ffffff"/>
	<fontspec id="font9" size="8" family="AkzidenzGroteskBE-It,Italic" color="#ffffff"/>
	<fontspec id="font10" size="8" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font11" size="6" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font12" size="17" family="LTMUXQ+Helvetica" color="#000000"/>
	<fontspec id="font13" size="17" family="LTMUXQ+Helvetica" color="#000000"/>
<text top="42" left="311" width="62" height="7" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="text"><b>Available online</b></text>
<text top="42" left="375" width="181" height="7" font="font2" id="p1_t2" reading_order_no="1" segment_no="0" tag_type="text">http://breast-cancer-research.com/content/7/1/R145</text>
<text top="735" left="569" width="19" height="8" font="font3" id="p1_t3" reading_order_no="141" segment_no="12" tag_type="text">R149</text>
<text top="389" left="57" width="241" height="9" font="font4" id="p1_t4" reading_order_no="17" segment_no="5" tag_type="text">tive with 66.3 cells, the parental cell line from which A2L2</text>
<text top="401" left="57" width="135" height="9" font="font4" id="p1_t5" reading_order_no="18" segment_no="5" tag_type="text">was derived by transfection with </text>
<text top="401" left="192" width="18" height="9" font="font5" id="p1_t6" reading_order_no="19" segment_no="5" tag_type="text"><i>neu </i></text>
<text top="401" left="211" width="72" height="9" font="font4" id="p1_t7" reading_order_no="20" segment_no="5" tag_type="text">(data not shown).</text>
<text top="424" left="57" width="238" height="8" font="font6" id="p1_t8" reading_order_no="21" segment_no="6" tag_type="title"><b>Protection from tumor challenge in a mammary fat pad </b></text>
<text top="436" left="57" width="231" height="8" font="font6" id="p1_t9" reading_order_no="22" segment_no="6" tag_type="title"><b>prevention model following vaccination with VRP-neu</b></text>
<text top="448" left="57" width="70" height="9" font="font4" id="p1_t10" reading_order_no="23" segment_no="7" tag_type="text">Groups of mice (</text>
<text top="448" left="127" width="8" height="9" font="font5" id="p1_t11" reading_order_no="24" segment_no="7" tag_type="text"><i>n </i></text>
<text top="448" left="135" width="162" height="9" font="font4" id="p1_t12" reading_order_no="25" segment_no="7" tag_type="text">= 7 per group) were vaccinated subcu-</text>
<text top="459" left="57" width="76" height="9" font="font4" id="p1_t13" reading_order_no="26" segment_no="7" tag_type="text">taneously with 10</text>
<text top="459" left="132" width="6" height="6" font="font7" id="p1_t14" reading_order_no="27" segment_no="7" tag_type="text">5 </text>
<text top="459" left="139" width="37" height="9" font="font4" id="p1_t15" reading_order_no="28" segment_no="7" tag_type="text">IU or 10</text>
<text top="459" left="176" width="6" height="6" font="font7" id="p1_t16" reading_order_no="29" segment_no="7" tag_type="text">6 </text>
<text top="459" left="183" width="34" height="9" font="font4" id="p1_t17" reading_order_no="30" segment_no="7" tag_type="text">IU VRP-</text>
<text top="459" left="217" width="18" height="9" font="font5" id="p1_t18" reading_order_no="31" segment_no="7" tag_type="text"><i>neu </i></text>
<text top="459" left="237" width="45" height="9" font="font4" id="p1_t19" reading_order_no="32" segment_no="7" tag_type="text">or with 10</text>
<text top="459" left="282" width="6" height="6" font="font7" id="p1_t20" reading_order_no="33" segment_no="7" tag_type="text">6 </text>
<text top="459" left="288" width="9" height="9" font="font4" id="p1_t21" reading_order_no="34" segment_no="7" tag_type="text">IU</text>
<text top="471" left="57" width="240" height="9" font="font4" id="p1_t22" reading_order_no="35" segment_no="7" tag_type="text">VRP-HA three times at 14-day intervals. Two weeks after</text>
<text top="483" left="57" width="240" height="9" font="font4" id="p1_t23" reading_order_no="36" segment_no="7" tag_type="text">the final vaccination, the mice were challenged with 2.5 ×</text>
<text top="495" left="57" width="11" height="9" font="font4" id="p1_t24" reading_order_no="37" segment_no="7" tag_type="text">10</text>
<text top="494" left="68" width="6" height="6" font="font7" id="p1_t25" reading_order_no="38" segment_no="7" tag_type="text">4 </text>
<text top="495" left="74" width="224" height="9" font="font4" id="p1_t26" reading_order_no="39" segment_no="7" tag_type="text">A2L2 cells injected into a mammary fat pad. Five weeks</text>
<text top="506" left="57" width="240" height="9" font="font4" id="p1_t27" reading_order_no="40" segment_no="7" tag_type="text">after tumor challenge, the largest tumor dimension was</text>
<text top="518" left="57" width="240" height="9" font="font4" id="p1_t28" reading_order_no="41" segment_no="7" tag_type="text">measured and the mice were killed. If a tumor was present,</text>
<text top="530" left="57" width="241" height="9" font="font4" id="p1_t29" reading_order_no="42" segment_no="7" tag_type="text">its mass was determined. All of the mice vaccinated with</text>
<text top="542" left="57" width="240" height="9" font="font4" id="p1_t30" reading_order_no="43" segment_no="7" tag_type="text">VRP-HA had a measurable tumor, whereas only one mouse</text>
<text top="553" left="57" width="142" height="9" font="font4" id="p1_t31" reading_order_no="44" segment_no="7" tag_type="text">in each group vaccinated with 10</text>
<text top="553" left="199" width="6" height="6" font="font7" id="p1_t32" reading_order_no="45" segment_no="7" tag_type="text">6 </text>
<text top="553" left="206" width="34" height="9" font="font4" id="p1_t33" reading_order_no="46" segment_no="7" tag_type="text">IU VRP-</text>
<text top="553" left="239" width="18" height="9" font="font5" id="p1_t34" reading_order_no="47" segment_no="7" tag_type="text"><i>neu </i></text>
<text top="553" left="259" width="23" height="9" font="font4" id="p1_t35" reading_order_no="48" segment_no="7" tag_type="text">or 10</text>
<text top="553" left="282" width="6" height="6" font="font7" id="p1_t36" reading_order_no="49" segment_no="7" tag_type="text">5 </text>
<text top="553" left="288" width="9" height="9" font="font4" id="p1_t37" reading_order_no="50" segment_no="7" tag_type="text">IU</text>
<text top="565" left="57" width="21" height="9" font="font4" id="p1_t38" reading_order_no="51" segment_no="7" tag_type="text">VRP-</text>
<text top="565" left="78" width="18" height="9" font="font5" id="p1_t39" reading_order_no="52" segment_no="7" tag_type="text"><i>neu </i></text>
<text top="565" left="97" width="201" height="9" font="font4" id="p1_t40" reading_order_no="53" segment_no="7" tag_type="text">had a measurable tumo<a href="">r (Fig. 2a,2b). These </a>find-</text>
<text top="577" left="57" width="240" height="9" font="font4" id="p1_t41" reading_order_no="54" segment_no="7" tag_type="text">ings clearly demonstrate that vaccination three times with</text>
<text top="589" left="57" width="37" height="9" font="font4" id="p1_t42" reading_order_no="55" segment_no="7" tag_type="text">either 10</text>
<text top="588" left="94" width="6" height="6" font="font7" id="p1_t43" reading_order_no="56" segment_no="7" tag_type="text">5 </text>
<text top="589" left="100" width="34" height="9" font="font4" id="p1_t44" reading_order_no="57" segment_no="7" tag_type="text">IU or 10</text>
<text top="588" left="134" width="6" height="6" font="font7" id="p1_t45" reading_order_no="58" segment_no="7" tag_type="text">6 </text>
<text top="589" left="140" width="33" height="9" font="font4" id="p1_t46" reading_order_no="59" segment_no="7" tag_type="text">IU VRP-</text>
<text top="589" left="173" width="18" height="9" font="font5" id="p1_t47" reading_order_no="60" segment_no="7" tag_type="text"><i>neu </i></text>
<text top="589" left="191" width="106" height="9" font="font4" id="p1_t48" reading_order_no="61" segment_no="7" tag_type="text">protected mice from chal-</text>
<text top="600" left="57" width="241" height="9" font="font4" id="p1_t49" reading_order_no="62" segment_no="7" tag_type="text">lenge with A2L2 cells. VRP-HA failed to provide protection</text>
<text top="612" left="57" width="240" height="9" font="font4" id="p1_t50" reading_order_no="63" segment_no="7" tag_type="text">for any of the mice, and therefore the protective effect was</text>
<text top="624" left="57" width="223" height="9" font="font4" id="p1_t51" reading_order_no="64" segment_no="7" tag_type="text">specific for the vaccine containing the gene for HER2/</text>
<text top="624" left="279" width="16" height="9" font="font5" id="p1_t52" reading_order_no="65" segment_no="7" tag_type="text"><i>neu</i></text>
<text top="624" left="295" width="2" height="9" font="font4" id="p1_t53" reading_order_no="66" segment_no="7" tag_type="text">.</text>
<text top="647" left="57" width="236" height="8" font="font6" id="p1_t54" reading_order_no="67" segment_no="10" tag_type="title"><b>Determination of the minimal effective vaccine dose in </b></text>
<text top="659" left="57" width="127" height="8" font="font6" id="p1_t55" reading_order_no="68" segment_no="10" tag_type="title"><b>two tumor prevention models</b></text>
<text top="671" left="57" width="167" height="9" font="font4" id="p1_t56" reading_order_no="69" segment_no="11" tag_type="text">Because vaccination three times with 10</text>
<text top="670" left="224" width="6" height="6" font="font7" id="p1_t57" reading_order_no="70" segment_no="11" tag_type="text">5 </text>
<text top="671" left="230" width="33" height="9" font="font4" id="p1_t58" reading_order_no="71" segment_no="11" tag_type="text">IU VRP-</text>
<text top="671" left="263" width="18" height="9" font="font5" id="p1_t59" reading_order_no="72" segment_no="11" tag_type="text"><i>neu </i></text>
<text top="671" left="281" width="16" height="9" font="font4" id="p1_t60" reading_order_no="73" segment_no="11" tag_type="text">pre-</text>
<text top="683" left="57" width="240" height="9" font="font4" id="p1_t61" reading_order_no="74" segment_no="11" tag_type="text">vented tumor growth in a mammary fat pad, we next deter-</text>
<text top="694" left="57" width="152" height="9" font="font4" id="p1_t62" reading_order_no="75" segment_no="11" tag_type="text">mined the minimum number of VRP-</text>
<text top="694" left="208" width="18" height="9" font="font5" id="p1_t63" reading_order_no="76" segment_no="11" tag_type="text"><i>neu </i></text>
<text top="694" left="228" width="70" height="9" font="font4" id="p1_t64" reading_order_no="77" segment_no="11" tag_type="text">particles and the</text>
<text top="706" left="57" width="241" height="9" font="font4" id="p1_t65" reading_order_no="78" segment_no="11" tag_type="text">minimum number of vaccinations necessary to significantly</text>
<text top="718" left="57" width="241" height="9" font="font4" id="p1_t66" reading_order_no="79" segment_no="11" tag_type="text">inhibit tumor growth. In the mammary fat pad prevention</text>
<text top="389" left="315" width="130" height="9" font="font4" id="p1_t67" reading_order_no="80" segment_no="4" tag_type="text">model, vaccination twice with 10</text>
<text top="388" left="445" width="6" height="6" font="font7" id="p1_t68" reading_order_no="81" segment_no="4" tag_type="text">5 </text>
<text top="389" left="451" width="32" height="9" font="font4" id="p1_t69" reading_order_no="82" segment_no="4" tag_type="text">IU VRP-</text>
<text top="389" left="483" width="18" height="9" font="font5" id="p1_t70" reading_order_no="83" segment_no="4" tag_type="text"><i>neu </i></text>
<text top="389" left="500" width="56" height="9" font="font4" id="p1_t71" reading_order_no="84" segment_no="4" tag_type="text">or vaccination</text>
<text top="401" left="315" width="87" height="9" font="font4" id="p1_t72" reading_order_no="85" segment_no="4" tag_type="text">three times with 10</text>
<text top="400" left="402" width="6" height="6" font="font7" id="p1_t73" reading_order_no="86" segment_no="4" tag_type="text">4 </text>
<text top="401" left="410" width="35" height="9" font="font4" id="p1_t74" reading_order_no="87" segment_no="4" tag_type="text">IU VRP-</text>
<text top="401" left="445" width="18" height="9" font="font5" id="p1_t75" reading_order_no="88" segment_no="4" tag_type="text"><i>neu </i></text>
<text top="401" left="466" width="90" height="9" font="font4" id="p1_t76" reading_order_no="89" segment_no="4" tag_type="text">completely prevented</text>
<text top="412" left="315" width="241" height="9" font="font4" id="p1_t77" reading_order_no="90" segment_no="4" tag_type="text">tumor growth in many mice and significantly reduced the</text>
<text top="424" left="315" width="241" height="9" font="font4" id="p1_t78" reading_order_no="91" segment_no="4" tag_type="text">tumor mass in the entire group compared with the tumor</text>
<text top="436" left="315" width="241" height="9" font="font4" id="p1_t79" reading_order_no="92" segment_no="4" tag_type="text">mass of the mice vaccinated three times with VRP-HA (Fig.</text>
<text top="448" left="315" width="241" height="9" font="font4" id="p1_t80" reading_order_no="93" segment_no="4" tag_type="text"><a href="">3a</a>). Identical results were obtained in the experimental lung</text>
<text top="459" left="315" width="241" height="9" font="font4" id="p1_t81" reading_order_no="94" segment_no="4" tag_type="text">metastasis prevention model, in which mice were injected</text>
<text top="471" left="315" width="241" height="9" font="font4" id="p1_t82" reading_order_no="95" segment_no="4" tag_type="text">with A2L2 cells intravenously in the tail vein after vaccination</text>
<text top="483" left="315" width="241" height="9" font="font4" id="p1_t83" reading_order_no="96" segment_no="4" tag_type="text"><a href="">(Fig. 3b</a>). These results demonstrate that, in both tumor mod-</text>
<text top="495" left="315" width="148" height="9" font="font4" id="p1_t84" reading_order_no="97" segment_no="4" tag_type="text">els, vaccination three times with 10</text>
<text top="494" left="463" width="6" height="6" font="font7" id="p1_t85" reading_order_no="98" segment_no="4" tag_type="text">4 </text>
<text top="495" left="470" width="33" height="9" font="font4" id="p1_t86" reading_order_no="99" segment_no="4" tag_type="text">IU VRP-</text>
<text top="495" left="503" width="18" height="9" font="font5" id="p1_t87" reading_order_no="100" segment_no="4" tag_type="text"><i>neu </i></text>
<text top="495" left="522" width="34" height="9" font="font4" id="p1_t88" reading_order_no="101" segment_no="4" tag_type="text">or twice</text>
<text top="506" left="315" width="31" height="9" font="font4" id="p1_t89" reading_order_no="102" segment_no="4" tag_type="text">with 10</text>
<text top="506" left="346" width="6" height="6" font="font7" id="p1_t90" reading_order_no="103" segment_no="4" tag_type="text">5 </text>
<text top="506" left="353" width="33" height="9" font="font4" id="p1_t91" reading_order_no="104" segment_no="4" tag_type="text">IU VRP-</text>
<text top="506" left="386" width="18" height="9" font="font5" id="p1_t92" reading_order_no="105" segment_no="4" tag_type="text"><i>neu </i></text>
<text top="506" left="405" width="151" height="9" font="font4" id="p1_t93" reading_order_no="106" segment_no="4" tag_type="text">significantly reduced the tumor mass</text>
<text top="518" left="315" width="241" height="9" font="font4" id="p1_t94" reading_order_no="107" segment_no="4" tag_type="text">and lung metastasis. In addition, several mice in each vacci-</text>
<text top="530" left="315" width="229" height="9" font="font4" id="p1_t95" reading_order_no="108" segment_no="4" tag_type="text">nated group were tumor free in mammary tissue or lungs.</text>
<text top="553" left="315" width="189" height="8" font="font6" id="p1_t96" reading_order_no="109" segment_no="8" tag_type="title"><b>Vaccination of MMTV-c-neu transgenic mice</b></text>
<text top="565" left="315" width="38" height="9" font="font4" id="p1_t97" reading_order_no="110" segment_no="9" tag_type="text">MMTV-c-</text>
<text top="565" left="353" width="18" height="9" font="font5" id="p1_t98" reading_order_no="111" segment_no="9" tag_type="text"><i>neu </i></text>
<text top="565" left="371" width="169" height="9" font="font4" id="p1_t99" reading_order_no="112" segment_no="9" tag_type="text">transgenic mice contain the activated rat </text>
<text top="565" left="540" width="16" height="9" font="font5" id="p1_t100" reading_order_no="113" segment_no="9" tag_type="text"><i>neu</i></text>
<text top="577" left="315" width="241" height="9" font="font4" id="p1_t101" reading_order_no="114" segment_no="9" tag_type="text">gene under the control of the MMTV promoter and sponta-</text>
<text top="589" left="315" width="70" height="9" font="font4" id="p1_t102" reading_order_no="115" segment_no="9" tag_type="text">neously develop </text>
<text top="589" left="385" width="16" height="9" font="font5" id="p1_t103" reading_order_no="116" segment_no="9" tag_type="text"><i>neu</i></text>
<text top="588" left="401" width="6" height="6" font="font7" id="p1_t104" reading_order_no="117" segment_no="9" tag_type="text">+ </text>
<text top="589" left="407" width="149" height="9" font="font4" id="p1_t105" reading_order_no="118" segment_no="9" tag_type="text">breast tumors within 110–120 days</text>
<text top="600" left="315" width="241" height="9" font="font4" id="p1_t106" reading_order_no="119" segment_no="9" tag_type="text"><a href="">[45]</a>. Without intervention, all of the mice die of breast</text>
<text top="612" left="315" width="166" height="9" font="font4" id="p1_t107" reading_order_no="120" segment_no="9" tag_type="text">cancer. We vaccinated groups of mice (</text>
<text top="612" left="481" width="8" height="9" font="font5" id="p1_t108" reading_order_no="121" segment_no="9" tag_type="text"><i>n </i></text>
<text top="612" left="489" width="67" height="9" font="font4" id="p1_t109" reading_order_no="122" segment_no="9" tag_type="text">= 10 per group)</text>
<text top="624" left="315" width="157" height="9" font="font4" id="p1_t110" reading_order_no="123" segment_no="9" tag_type="text">three times at 14-day intervals with 10</text>
<text top="623" left="473" width="6" height="6" font="font7" id="p1_t111" reading_order_no="124" segment_no="9" tag_type="text">6 </text>
<text top="624" left="478" width="33" height="9" font="font4" id="p1_t112" reading_order_no="125" segment_no="9" tag_type="text">IU VRP-</text>
<text top="624" left="511" width="18" height="9" font="font5" id="p1_t113" reading_order_no="126" segment_no="9" tag_type="text"><i>neu </i></text>
<text top="624" left="530" width="22" height="9" font="font4" id="p1_t114" reading_order_no="127" segment_no="9" tag_type="text">or 10</text>
<text top="623" left="552" width="4" height="6" font="font7" id="p1_t115" reading_order_no="128" segment_no="9" tag_type="text">6</text>
<text top="636" left="315" width="241" height="9" font="font4" id="p1_t116" reading_order_no="129" segment_no="9" tag_type="text">IU VRP-HA and determined the effect on survival. Eight of</text>
<text top="647" left="315" width="240" height="9" font="font4" id="p1_t117" reading_order_no="130" segment_no="9" tag_type="text">the 10 mice vaccinated with VRP-HA were killed by 140</text>
<text top="659" left="315" width="240" height="9" font="font4" id="p1_t118" reading_order_no="131" segment_no="9" tag_type="text">days owing to moribundity, and the remaining two mice</text>
<text top="671" left="315" width="241" height="9" font="font4" id="p1_t119" reading_order_no="132" segment_no="9" tag_type="text">were killed on day 195 (F<a href="">ig. 4)</a>. None of the mice vacci-</text>
<text top="683" left="315" width="71" height="9" font="font4" id="p1_t120" reading_order_no="133" segment_no="9" tag_type="text">nated with VRP-</text>
<text top="683" left="386" width="18" height="9" font="font5" id="p1_t121" reading_order_no="134" segment_no="9" tag_type="text"><i>neu </i></text>
<text top="683" left="406" width="149" height="9" font="font4" id="p1_t122" reading_order_no="135" segment_no="9" tag_type="text">showed any sign of illness at 240</text>
<text top="694" left="315" width="241" height="9" font="font4" id="p1_t123" reading_order_no="136" segment_no="9" tag_type="text">days, and breast tumors were not evident on palpation. The</text>
<text top="706" left="315" width="72" height="9" font="font4" id="p1_t124" reading_order_no="137" segment_no="9" tag_type="text">mice in the VRP-</text>
<text top="706" left="387" width="16" height="9" font="font5" id="p1_t125" reading_order_no="138" segment_no="9" tag_type="text"><i>neu</i></text>
<text top="706" left="403" width="153" height="9" font="font4" id="p1_t126" reading_order_no="139" segment_no="9" tag_type="text">-vaccinated group were killed at this</text>
<text top="718" left="315" width="241" height="9" font="font4" id="p1_t127" reading_order_no="140" segment_no="9" tag_type="text">time, and gross pathologic examination of the breasts fol-</text>
<text top="85" left="57" width="31" height="7" font="font0" id="p1_t128" reading_order_no="2" segment_no="1" tag_type="title"><b>Figure 1</b></text>
<text top="343" left="57" width="376" height="7" font="font8" id="p1_t129" reading_order_no="5" segment_no="3" tag_type="text">Flow cytometric analysis of A2L2 cells with serum from mice vaccinated with virus-like replicon particles (VRP)-</text>
<text top="343" left="432" width="15" height="7" font="font9" id="p1_t130" reading_order_no="6" segment_no="3" tag_type="text"><i>neu </i></text>
<text top="343" left="448" width="92" height="7" font="font8" id="p1_t131" reading_order_no="7" segment_no="3" tag_type="text">or VRP-hemagglutinin (HA)</text>
<text top="343" left="448" width="96" height="7" font="font2" id="p1_t132" reading_order_no="8" segment_no="3" tag_type="text">or VRP-hemagglutinin (HA). </text>
<text top="352" left="57" width="267" height="7" font="font2" id="p1_t133" reading_order_no="9" segment_no="3" tag_type="text">Serum was collected 2 weeks after a single vaccination of Balb/c mice with 10</text>
<text top="352" left="324" width="5" height="5" font="font11" id="p1_t134" reading_order_no="10" segment_no="3" tag_type="text">6 </text>
<text top="352" left="329" width="27" height="7" font="font2" id="p1_t135" reading_order_no="11" segment_no="3" tag_type="text">IU VRP-</text>
<text top="352" left="356" width="15" height="7" font="font10" id="p1_t136" reading_order_no="12" segment_no="3" tag_type="text"><i>neu </i></text>
<text top="352" left="371" width="62" height="7" font="font2" id="p1_t137" reading_order_no="13" segment_no="3" tag_type="text">(filled curve) or 10</text>
<text top="352" left="433" width="5" height="5" font="font11" id="p1_t138" reading_order_no="14" segment_no="3" tag_type="text">6 </text>
<text top="352" left="438" width="113" height="7" font="font2" id="p1_t139" reading_order_no="15" segment_no="3" tag_type="text">IU VRP-HA (open curve). The pri-</text>
<text top="362" left="57" width="488" height="7" font="font2" id="p1_t140" reading_order_no="16" segment_no="3" tag_type="text">mary serum was diluted with PBS (1:100), and FITC-labeled goat anti-mouse IgG diluted in PBS (1:1000) was used as the secondary antibody.</text>
<text top="297" left="272" width="99" height="22" font="font12" id="p1_t141" reading_order_no="4" segment_no="2" tag_type="figure">Fluorescence</text>
<text top="210" left="84" width="0" height="22" font="font13" id="p1_t142" reading_order_no="3" segment_no="2" tag_type="figure">Counts</text>
</page>
</pdf2xml>
